Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Bantscheff

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
BMC Cancer|January 27, 2012
Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomicsArmin Haupt, Gerard Joberty, Marcus Bantscheff, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2021
One-Step Synthesis of Photoaffinity Probes for Live-Cell MS-Based ProteomicsDavid J Fallon, Stephanie Lehmann, Chun-Wa Chung, et al.
Science (New York, N.Y.)|October 4, 2014
Tracking cancer drugs in living cells by thermal profiling of the proteomeMikhail M Savitski, Friedrich B M Reinhard, Holger Franken, et al.
Nature Communications|February 17, 2018
Systematic analysis of protein turnover in primary cellsToby Mathieson, Holger Franken, Jan Kosinski, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Discovery of GSK8612, a Highly Selective and Potent TBK1 InhibitorDouglas W Thomson, Daniel Poeckel, Nico Zinn, et al.
G3 (Bethesda, Md.)|April 9, 2020
Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell LinesWilliam F Mueller, Petra Jakob, Han Sun, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Journal of Medicinal Chemistry|June 8, 2017
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell LinesDouglas W Thomson, Anne J Wagner, Marcus Bantscheff, et al.
Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.
Journal of Biochemistry|December 8, 2021
Patient-derived gene and protein expression signatures of NGLY1 deficiencyBenedikt Rauscher, William F Mueller, Sandra Clauder-Münster, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
BMC Cancer|January 27, 2012
Hsp90 inhibition differentially destabilises MAP kinase and TGF-beta signalling components in cancer cells revealed by kinase-targeted chemoproteomicsArmin Haupt, Gerard Joberty, Marcus Bantscheff, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|July 30, 2021
One-Step Synthesis of Photoaffinity Probes for Live-Cell MS-Based ProteomicsDavid J Fallon, Stephanie Lehmann, Chun-Wa Chung, et al.
Science (New York, N.Y.)|October 4, 2014
Tracking cancer drugs in living cells by thermal profiling of the proteomeMikhail M Savitski, Friedrich B M Reinhard, Holger Franken, et al.
Nature Communications|February 17, 2018
Systematic analysis of protein turnover in primary cellsToby Mathieson, Holger Franken, Jan Kosinski, et al.
ACS Medicinal Chemistry Letters|May 18, 2019
Discovery of GSK8612, a Highly Selective and Potent TBK1 InhibitorDouglas W Thomson, Daniel Poeckel, Nico Zinn, et al.
G3 (Bethesda, Md.)|April 9, 2020
Loss of N-Glycanase 1 Alters Transcriptional and Translational Regulation in K562 Cell LinesWilliam F Mueller, Petra Jakob, Han Sun, et al.
Molecular & Cellular Proteomics : MCP|August 10, 2014
Ion mobility tandem mass spectrometry enhances performance of bottom-up proteomicsDominic Helm, Johannes P C Vissers, Christopher J Hughes, et al.
Journal of Medicinal Chemistry|June 8, 2017
Discovery of a Highly Selective Tankyrase Inhibitor Displaying Growth Inhibition Effects against a Diverse Range of Tumor Derived Cell LinesDouglas W Thomson, Anne J Wagner, Marcus Bantscheff, et al.
Nature Biotechnology|August 28, 2007
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitorsMarcus Bantscheff, Dirk Eberhard, Yann Abraham, et al.
Journal of Biochemistry|December 8, 2021
Patient-derived gene and protein expression signatures of NGLY1 deficiencyBenedikt Rauscher, William F Mueller, Sandra Clauder-Münster, et al.
Pageof 12